Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Alopecia Areata patients have low zinc and high copper levels.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Celiac patients may have kidney function risks due to increased urea and creatinine and decreased magnesium, zinc, and vitamin C.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Organs like hair follicles can renew themselves in complex ways, adapting to different needs and environments.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Higher IL-17A levels indicate more severe alopecia areata.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

People with alopecia areata often have lower vitamin D levels than healthy people.